Concepedia

Kazuma Shimanaka

KS

Statistics

Publications

6

Citations

220

H-Index

6

Active since

2021

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Michigan State University

Purdue University West Lafayette

Kazuma Shimanaka is an author at Brigham and Women's Hospital specializing in protein aggregation disorders, alpha-synuclein aggregation, and parkinson disease.

ORCID

Publications per year

2021–2024

6

Publications

6

Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity

Nagendran Ramalingam, Shan‐Xue Jin, Tim E. Moors et al. · npj Parkinson s Disease · 2023 · 147 citations · Full text

, , +17

A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity

Silke Nuber, Chee Yeun Chung, Daniel F. Tardiff et al. · Neurotherapeutics · 2022 · 25 citations · Full text

, , +17

Anti-fibrillization effects of sulfonamide derivatives on α-synuclein and hyperphosphorylated tau isoform 1N4R

Jessica S. Fortin, Kazuma Shimanaka, A. Prasanth Saraswati et al. · Journal of Molecular Structure · 2022 · 14 citations · Full text

, , +16

Structural basis for Mis18 complex assembly and its implications for centromere maintenance

Reshma Thamkachy, Bethan Medina‐Pritchard, Sang Ho Park et al. · EMBO Reports · 2024 · 13 citations · Full text

, , +17

In vitro characterization of urea derivatives to inhibit alpha-synuclein early-stage aggregation

Soham Maity, Kazuma Shimanaka, Laken N. Rivet et al. · Journal of Molecular Structure · 2021 · 11 citations

, , +14

1–5 of 6